Abbonarsi

“Spice”-related deaths in and around Munich, Germany: A retrospective look at the role of synthetic cannabinoids in our postmortem cases over a seven-year period (2014–2020) - 15/08/22

Doi : 10.1016/j.toxac.2022.06.323 
Olwen Groth 1, , Gabriele Roider 1, Verena Angerer 2, 3, Jan Schäper 4, Matthias Graw 1, Frank Musshoff 5, Volker Auwärter 2
1 Institute of Forensic Medicine, University of Munich, Munich, Germany 
2 Institute of Forensic Medicine, University Medical Centre Freiburg, Freiburg, Germany 
3 Institute of Forensic Medicine, Forensic Toxicology, Kantonsspital St. Gallen, 9010 St. Gallen, Switzerland 
4 Bavarian State Criminal Police Office (BLKA), Forensic Science Institute, Munich, Germany 
5 Forensic Toxicological Centre (FTC) Munich, Dessauerstrasse 13-15, 80992 Munich, Germany 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Riassunto

Objective

The synthetic cannabinoid receptor agonists (SCRAs, “Spice”) are a diverse group of recreational drugs, with their structural and pharmacological differences still evolving. Due to limited data on their pharmacokinetics and pharmacodynamics in humans, the assessment of their role in fatal cases remains challenging. Forensic toxicologists thus often rely on previous reports of intoxication cases. This work provides detailed information on forensic cases for which SCRAs could be detected in postmortem specimens.

Methods

All cases included underwent an autopsy at the Institute of Forensic Medicine in Munich between 2014 and 2020, followed by routine toxicological analyses, including analysis for alcohol. Pharmaceutical substances and classical drugs of abuse were detected and quantified in postmortem femoral venous blood (or liver where not available) by liquid chromatography-tandem mass spectrometry (LC-MS/MS) at the Forensic Toxicological Centre Munich. Based on circumstantial data and case histories, additional targeted analyses for the detection of SCRAs and other new psychoactive substances were performed on those cases for which a prior consumption was indicated or suspected. Synthetic cannabinoids were detected and quantified in femoral venous blood (81 cases), cardiac blood (12 cases), liver tissue (2 cases), antemortem blood (2 cases) and urine (1 case) by LC-MS/MS at the Institute of Forensic Medicine in Freiburg, Germany.

The cause of death and the roles of the SCRAs in the individual fatalities were assessed based on the concentrations detected, the presence and concentrations of other drugs, pathological findings at autopsy and case histories. Furthermore, the total number of SCRAs detected and how these substances were scattered over the investigated period (i.e. how often a particular substance was detected each year) were determined. The latter was correlated with the number of SCRAs detected in police seizures analysed at the Bavarian State Criminal Police Office (BLKA), as well as the change in their legal status in Germany. The concentration range for each SCRA detected in femoral venous blood was defined and correlated with the estimated interval between death and sample collection.

Results

We were able to identify 98 “Spice”-related fatalities among our autopsy cases from 2014 to 2020. Most of the deceased were male (91.8%), with a median age of 36years. SCRAs played a causative role in 51%, a contributory role in 26% and no significant role in 23% of cases. The most common cause of death was polydrug intoxications that include synthetic cannabinoids.

Altogether 41 different synthetic cannabinoids could be detected during the investigated period. 5F-ADB was the most prevalent SCRA among our cases (n=25), at median and maximum concentrations in femoral venous blood of 0.22μg/L and 14μg/L, respectively, followed by 5F-MDMB-PICA (0.64μg/L; 7.2μg/L) and AB-CHMINACA (3.95μg/L; 28μg/L). Cumyl-CBMICA and 5F-MDMB-P7AICA were two of the least frequently detected synthetic cannabinoids. These results correlate with the number of SCRAs detected in local police seizures. No direct correlation between synthetic cannabinoid concentrations and postmortem interval was evident from our results.

Our awareness of the importance of SCRAs in fatal intoxication cases has clearly increased since 2014, as is evident from our numbers in toxicological analyses for their postmortem detection. Nonetheless, the number of identified “Spice”-related fatalities has significantly decreased in our cohort of cases after the New Psychoactive Substances Act was implemented in Germany. Furthermore, the causative role of SCRAs in these fatalities has since also diminished in significance.

Conclusion

Considering the continuing evolvement of SCRAs and the limited knowledge about their pharmacology, postmortem distribution and stability in humans, forensic toxicologists will undoubtedly benefit from more detailed postmortem case studies to assess their role in fatal intoxication cases.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2022  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 34 - N° 3S

P. S19 - Settembre 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Blood simultaneous determination of PEth 16:0/18:1, PEth 16:0/20:4 and ethylglucuronide using DBS: Application to a clinical study of patients hospitalized for withdrawal
  • Florian Hakim, Alexandr Gish, Jean-François Wiart, Camille Richeval, Damien Scliffet, Olivier Cottencin, Delphine Allorge, Jean-Michel Gaulier
| Articolo seguente Articolo seguente
  • “Looking outside the forensic toxicology box – An approach to link results from the lab to public health”
  • Stefania Oliverio, Ariana Zeka, Giovanni Leonardi, Vincent Varlet

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.